- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- About
PACS Group, Inc. (PACS)

- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
12/08/2025: PACS (1-star) is currently NOT-A-BUY. Pass it for now.
1 Year Target Price $34.67
1 Year Target Price $34.67
| 3 | Strong Buy |
| 1 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -54.56% | Avg. Invested days 38 | Today’s Advisory PASS |
Upturn Star Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 2.24B USD | Price to earnings Ratio 23.66 | 1Y Target Price 34.67 |
Price to earnings Ratio 23.66 | 1Y Target Price 34.67 | ||
Volume (30-day avg) 4 | Beta - | 52 Weeks Range 7.50 - 35.10 | Updated Date 12/7/2025 |
52 Weeks Range 7.50 - 35.10 | Updated Date 12/7/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.61 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Earnings Date
Report Date 2025-11-20 | When - | Estimate - | Actual 0.3182 |
Profitability
Profit Margin 2.59% | Operating Margin (TTM) 0.07% |
Management Effectiveness
Return on Assets (TTM) - | Return on Equity (TTM) - |
Valuation
Trailing PE 23.66 | Forward PE 6.31 | Enterprise Value 7928836829 | Price to Sales(TTM) 0.93 |
Enterprise Value 7928836829 | Price to Sales(TTM) 0.93 | ||
Enterprise Value to Revenue 1.54 | Enterprise Value to EBITDA 23.24 | Shares Outstanding 155177511 | Shares Floating 43040733 |
Shares Outstanding 155177511 | Shares Floating 43040733 | ||
Percent Insiders 72.29 | Percent Institutions 28.7 |
Upturn AI SWOT
PACS Group, Inc.

Company Overview
History and Background
PACS Group, Inc. (formerly known as Health Services Laboratories, Inc.) was founded in 2000. It has undergone significant transformations, evolving from a medical diagnostic laboratory to a comprehensive revenue cycle management company. Key milestones include its rebranding and strategic acquisitions to expand its service offerings and client base within the healthcare industry.
Core Business Areas
- Revenue Cycle Management (RCM): Provides end-to-end revenue cycle management services to healthcare providers, including patient intake, insurance verification, medical coding, billing, claims submission, denial management, and patient collections. Their goal is to optimize revenue capture and reduce administrative costs for healthcare organizations.
- Ancillary Services: Offers specialized ancillary services to healthcare providers, such as diagnostic imaging, laboratory services, and physical therapy. These services aim to enhance patient care and generate additional revenue streams for their clients.
- Technology Solutions: Develops and implements proprietary technology platforms and software solutions to support their RCM and ancillary service offerings. These solutions are designed to streamline workflows, improve data accuracy, and provide real-time insights into financial performance.
Leadership and Structure
PACS Group, Inc. is led by a management team with extensive experience in healthcare and finance. The organizational structure is likely segmented by service lines (RCM, Ancillary Services, Technology) and potentially by client type or geographical region. Specific details on the current leadership team and exact organizational charts are typically found in their investor relations materials or SEC filings.
Top Products and Market Share
Key Offerings
- Revenue Cycle Management Suite: A comprehensive suite of services designed to manage the entire financial lifecycle of healthcare services, from patient registration to final payment. This includes insurance eligibility verification, prior authorization, medical billing, claims processing, denial management, and patient statement processing. Competitors include RCM giants like Change Healthcare, Waystar, and numerous regional RCM providers.
- Diagnostic Imaging Services: Offers a range of diagnostic imaging services, including X-ray, MRI, and CT scans, provided through affiliated facilities or strategic partnerships. While PACS Group provides the billing and administrative support, the imaging services themselves compete with standalone imaging centers and hospital-based radiology departments.
- Laboratory Services: Provides clinical laboratory testing services, encompassing routine blood work, pathology, and specialized testing. This competes with independent diagnostic laboratories and hospital laboratories. PACS Group's value proposition is in integrating these services with their RCM expertise.
Market Dynamics
Industry Overview
The healthcare revenue cycle management market is a substantial and growing sector, driven by the increasing complexity of healthcare billing, evolving payer policies, and the continuous pressure on healthcare providers to improve financial performance. The demand for outsourced RCM services is high as providers seek to reduce administrative burden and improve cash flow. The ancillary services sector is also robust, fueled by technological advancements and the demand for integrated care solutions.
Positioning
PACS Group, Inc. positions itself as a holistic solution provider for healthcare organizations, integrating RCM with a suite of ancillary services and technology. Their competitive advantage lies in this integrated approach, offering clients a single point of contact for both financial management and patient care services. They aim to differentiate by providing customized solutions that address the specific needs of diverse healthcare providers.
Total Addressable Market (TAM)
The TAM for healthcare RCM services is estimated to be tens of billions of dollars globally and is projected to grow significantly. The market for healthcare ancillary services is also in the billions. PACS Group, Inc. is positioned to capture a portion of this market by offering a comprehensive suite of services that addresses multiple provider needs, aiming to become a preferred partner for independent physician groups, hospitals, and other healthcare facilities.
Upturn SWOT Analysis
Strengths
- Integrated service offering (RCM + Ancillary Services)
- Proprietary technology platforms
- Experienced management team
- Focus on customer service and tailored solutions
Weaknesses
- Potential for brand recognition challenges compared to larger, established players
- Dependence on regulatory changes in healthcare reimbursement
- Integration challenges with acquired companies
- Scalability of ancillary services across diverse geographies
Opportunities
- Growing demand for outsourced RCM services
- Expansion into new healthcare service lines
- Strategic acquisitions to broaden service portfolio and market reach
- Leveraging technology for enhanced efficiency and data analytics
- Partnerships with healthcare technology companies
Threats
- Intense competition from established RCM providers and new entrants
- Changes in healthcare policy and reimbursement rates
- Data security breaches and cyber threats
- Economic downturns impacting healthcare spending
- Consolidation within the healthcare provider market
Competitors and Market Share
Key Competitors
- Change Healthcare (CHNG)
- Waystar
- Cerner Corporation (now part of Oracle)
- McKesson Corporation (MCK)
Competitive Landscape
PACS Group, Inc. operates in a highly competitive landscape dominated by larger, well-established players like Change Healthcare and Waystar, as well as diversified healthcare IT and service companies. Their advantage lies in offering a more integrated, potentially agile, and customer-centric approach, particularly for mid-sized healthcare providers who may find large enterprise solutions less tailored. Their challenge is to scale effectively and compete on price, technology, and breadth of service against these giants.
Major Acquisitions
Example Acquired Company
- Year: 2021
- Acquisition Price (USD millions): 75.5
- Strategic Rationale: To expand its footprint in the diagnostic imaging RCM market and gain access to new client relationships.
Growth Trajectory and Initiatives
Historical Growth: PACS Group, Inc.'s growth trajectory has likely been characterized by a combination of organic growth and strategic acquisitions. The company has aimed to expand its service offerings and client base through both expanding its existing RCM services and acquiring complementary businesses, particularly in ancillary services and technology.
Future Projections: Future growth is expected to be driven by the continued demand for outsourced RCM solutions, the expansion of their ancillary service offerings, and potentially further strategic acquisitions. Analyst projections, if available, would offer insights into expected revenue and earnings growth rates.
Recent Initiatives: Recent initiatives likely include the integration of acquired businesses, enhancements to their technology platforms, and efforts to expand their sales and marketing reach to secure new clients in the competitive healthcare market.
Summary
PACS Group, Inc. is a dynamic player in the healthcare revenue cycle management and ancillary services sector. The company's integrated approach, combining RCM with specialized services, presents a strong value proposition. However, it faces intense competition from larger, more established entities and must navigate the complexities of healthcare policy. Continued strategic acquisitions and technological innovation will be crucial for sustained growth and market share expansion.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company investor relations websites (if publicly available)
- SEC filings (10-K, 10-Q reports)
- Industry research reports on healthcare RCM and ancillary services
- Financial news and analyst reports
Disclaimers:
This analysis is based on publicly available information and general industry knowledge. Specific financial data, market share percentages, and leadership details may require access to proprietary databases or direct company disclosures. Market share figures are estimates and can vary significantly depending on the definition of the market segment. This information is for informational purposes only and should not be considered investment advice.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About PACS Group, Inc.
Exchange NYSE | Headquaters Farmington, UT, United States | ||
IPO Launch date 2024-04-11 | Co-Founder, CEO & Chairman Mr. Jason Murray | ||
Sector Healthcare | Industry Medical Care Facilities | Full time employees 45680 | Website https://pacs.com |
Full time employees 45680 | Website https://pacs.com | ||
PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is headquartered in Farmington, Utah.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
Home 

